Scarica l'app Stockscreener
75.63
1.46%
-1.12
Dopo l'orario di chiusura:
75.69
0.06
+0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$76.75
Aprire:
$76.73
Volume 24 ore:
7.23M
Relative Volume:
0.98
Capitalizzazione di mercato:
$96.01B
Reddito:
$393.94B
Utile/perdita netta:
$428.00M
Rapporto P/E:
197.67
EPS:
0.3826
Flusso di cassa netto:
$6.29B
1 W Prestazione:
-5.89%
1M Prestazione:
-3.72%
6M Prestazione:
+19.90%
1 anno Prestazione:
+33.01%
Intervallo 1D:
$74.98
$76.89
Intervallo di 1 settimana:
$74.14
$81.06
Portata 52W:
$43.56
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
75.63 | 97.43B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
330.91 | 302.09B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
330.75 | 74.11B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
265.44 | 71.70B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
257.85 | 30.43B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Report: CVS settles insulin pen lawsuit for nearly $38M - Providence Business News
Cvs Health generates over $474 billion in 2024 U.S. economic impact, supporting communities throughout the United States - marketscreener.com
CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States - CVS Health
CVS Health (NYSE: CVS) reports $474B U.S. economic impact, 1.3M jobs supported - Stock Titan
CVS Health (CVS) Analyst Rating Update: Target Price Raised by B - GuruFocus
CVS Health stock price target raised to $86 from $77 at Bernstein - Investing.com India
Bernstein Adjusts CVS Health Price Target to $86 From $77 - marketscreener.com
CVS Health to Outline Double-Digit EPS Growth Path at Investor Day, RBC Says - marketscreener.com
CVS Health stock rating reiterated at Outperform by RBC ahead of Investor Day By Investing.com - Investing.com
Cvs Health Corp implementing end-to-end generative AI capabilities into Aetna Health app - marketscreener.com
Aetna (NYSE: CVS) rolls out AI-enabled app, bundled prior auths to cut 30-day readmits - Stock Titan
Lido Advisors LLC Raises Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by M&T Bank Corp - MarketBeat
Q3 Earnings Review: Health Insurance Providers Stocks Led by CVS Health (NYSE:CVS) - Finviz
Schroder Investment Management Group Raises Position in CVS Health Corporation $CVS - MarketBeat
2 Soaring Healthcare Stocks to Buy and Hold for a Decade - Finviz
CW Advisors LLC Raises Position in CVS Health Corporation $CVS - MarketBeat
Investors Pack Into CVS Ahead Of Make-Or-Break Update - Finimize
Wells Fargo Notes Solid Q3 Results for CVS but Moderates 2025 Bull Case for HCB Segment - Insider Monkey
What's Going On With CVS Health Stock Wednesday?CVS Health (NYSE:CVS) - Benzinga
CVS settles insulin pen lawsuit for $37.8M - The Business Journals
Cornerstone Community Development, CVS Health announce Prichard Centennial Residential Reveal - Drug Store News
CVS Health stock maintains Buy rating at UBS ahead of investor day By Investing.com - Investing.com
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Northwestern Mutual Wealth Management Co. Has $8.58 Million Stake in CVS Health Corporation $CVS - MarketBeat
Invesco Ltd. Acquires 3,118,626 Shares of CVS Health Corporation $CVS - MarketBeat
Arrowstreet Capital Limited Partnership Raises Holdings in CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation (Common Stock) (CVS0) stock undervalued at current price2025 EndofYear Setup & High Accuracy Trade Alerts - Newser
Healthcare Heavyweights Stumble On Legal And Trial Setbacks - Finimize
CVS Settles Healthcare Fraud Allegations with $37.76M Payment - GuruFocus
CVS Will Pay $37.8M To Settle Insulin Pen Overbilling Claims - Law360
CVS Health (CVS) Settles $37.76M Overbilling Allegations - GuruFocus
CVS to pay $37.8 million to settle claims over insulin pens - Yahoo! Finance Canada
CVS to pay $37.8 million to settle claims over insulin pens | Business Information & News | FE - Westlaw Today
Aetna Medicaid increases support to help end hunger in local communities - CVS Health
Panagora Asset Management Inc. Boosts Stake in CVS Health Corporation $CVS - MarketBeat
Shelton Capital Management Buys 94,433 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Level Four Advisory Services LLC - MarketBeat
Leuthold Group LLC Acquires New Shares in CVS Health Corporation $CVS - MarketBeat
Can CVS Health Corporation (Common Stock) (CVS0) stock stage a strong rebound this quarterJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - Newser
Brandes Investment Partners LP Buys 23,996 Shares of CVS Health Corporation $CVS - MarketBeat
Will CVS Health Corporation (CVS) stock maintain strong growth - Newser
CVS Health (NYSE: CVS) joins Prichard reveal after over $21M WV housing push - Stock Titan
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Groupama Asset Managment Increases Position in CVS Health Corporation $CVS - MarketBeat
American Century Companies Inc. Sells 225,537 Shares of CVS Health Corporation $CVS - MarketBeat
Virtue Capital Management LLC Reduces Stock Holdings in CVS Health Corporation $CVS - MarketBeat
New York State Common Retirement Fund Sells 256,264 Shares of CVS Health Corporation $CVS - MarketBeat
Scotia Capital Inc. Increases Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Laurel Wealth Advisors LLC Boosts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Boston Partners Invests $3.32 Million in CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.82%
1.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):